159 related articles for article (PubMed ID: 14616870)
21. Effects of IL-4 and IL-13 on total and allergen specific IgE production by cultured PBMC from allergic patients determined with recombinant pollen allergens.
Dolecek C; Steinberger P; Susani M; Kraft D; Valenta R; Boltz-Nitulescu G
Clin Exp Allergy; 1995 Sep; 25(9):879-89. PubMed ID: 8564727
[TBL] [Abstract][Full Text] [Related]
22. Allergen-induced synthesis of interleukin-5, but not of IgE, is a key mechanism linked to symptomatic episodes of seasonal allergic rhinitis in sensitized individuals.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Masamoto T; Kato A; Washio Y; Yamada K; Hayashi M; Ohmoto Y
Scand J Immunol; 1998 Jun; 47(6):596-602. PubMed ID: 9652829
[TBL] [Abstract][Full Text] [Related]
23. Allergen-induced cytokine secretion in relation to atopic symptoms and immunoglobulin E and immunoglobulin G subclass antibody responses.
Jenmalm MC; Björkstén B; Macaubas C; Holt BJ; Smallacombe TB; Holt PG
Pediatr Allergy Immunol; 1999 Aug; 10(3):168-77. PubMed ID: 10565557
[TBL] [Abstract][Full Text] [Related]
24. In vitro kinetics of allergen- and microbe-induced IL-4 and IFN-gamma mRNA expression in PBMC of pollen-allergic patients.
Laaksonen K; Waris M; Mäkelä MJ; Terho EO; Savolainen J
Allergy; 2003 Jan; 58(1):62-6. PubMed ID: 12580809
[TBL] [Abstract][Full Text] [Related]
25. Differences in IL-4 release by PBMC are related with heterogeneity of atopy.
Pène J; Rivier A; Lagier B; Becker WM; Michel FB; Bousquet J
Immunology; 1994 Jan; 81(1):58-64. PubMed ID: 8132221
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy.
Lou W; Wang C; Wang Y; Han D; Zhang L
Int Arch Allergy Immunol; 2012; 159(4):391-8. PubMed ID: 22846686
[TBL] [Abstract][Full Text] [Related]
27. Allergen-induced CD23 on CD4+ T lymphocytes and CD21 on B lymphocytes in patients with allergic asthma: evidence and regulation.
Gagro A; Rabatić S
Eur J Immunol; 1994 May; 24(5):1109-14. PubMed ID: 7910139
[TBL] [Abstract][Full Text] [Related]
28. Allergen induced cytokine profiles in type I allergic individuals before and after immunotherapy.
Söderlund A; Gabrielsson S; Paulie S; Hammarström ML; Rak S; Troye-Blomberg M
Immunol Lett; 1997 Jun; 57(1-3):177-81. PubMed ID: 9232448
[TBL] [Abstract][Full Text] [Related]
29. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
[TBL] [Abstract][Full Text] [Related]
30. Lol p I-induced IL-4 and IFN-gamma production by peripheral blood mononuclear cells of atopic and nonatopic subjects during and out of the pollen season.
Gagnon R; Akoum A; Hébert J
J Allergy Clin Immunol; 1993 Apr; 91(4):950-6. PubMed ID: 8473684
[TBL] [Abstract][Full Text] [Related]
31. A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation and T-Helper Type 2 and B-Cell Responses in Grass Pollen-induced Allergic Inflammation.
Qaseem AS; Singh I; Pathan AA; Layhadi JA; Parkin R; Alexandra F; Durham SR; Kishore U; Shamji MH
Am J Respir Crit Care Med; 2017 Dec; 196(12):1526-1534. PubMed ID: 28915062
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors.
Frotscher B; Anton K; Worm M
J Invest Dermatol; 2002 Nov; 119(5):1059-64. PubMed ID: 12445193
[TBL] [Abstract][Full Text] [Related]
33. Environmental antigen-induced IL-13 responses are elevated among subjects with allergic rhinitis, are independent of IL-4, and are inhibited by endogenous IFN-gamma synthesis.
Li Y; Simons FE; HayGlass KT
J Immunol; 1998 Dec; 161(12):7007-14. PubMed ID: 9862737
[TBL] [Abstract][Full Text] [Related]
34. Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children.
Jenmalm MC; Van Snick J; Cormont F; Salman B
Clin Exp Allergy; 2001 Oct; 31(10):1528-35. PubMed ID: 11678852
[TBL] [Abstract][Full Text] [Related]
35. Regulation of cytokine production by soluble CD23: costimulation of interferon gamma secretion and triggering of tumor necrosis factor alpha release.
Armant M; Ishihara H; Rubio M; Delespesse G; Sarfati M
J Exp Med; 1994 Sep; 180(3):1005-11. PubMed ID: 8064221
[TBL] [Abstract][Full Text] [Related]
36. Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.
Jahnz-Rózyk K; Targowski T; Głodzinska-Wyszogrodzka E; Płusa T
Allergy; 2003 Jul; 58(7):595-601. PubMed ID: 12823117
[TBL] [Abstract][Full Text] [Related]
37. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.
Scadding GW; Calderon MA; Bellido V; Koed GK; Nielsen NC; Lund K; Togias A; Phippard D; Turka LA; Hansel TT; Durham SR; Wurtzen PA
J Immunol Methods; 2012 Oct; 384(1-2):25-32. PubMed ID: 22759401
[TBL] [Abstract][Full Text] [Related]
38. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis.
Kopp MV; Brauburger J; Riedinger F; Beischer D; Ihorst G; Kamin W; Zielen S; Bez ; Friedrichs F; Von Berg A; Gerhold K; Hamelmann E; Hultsch ; Kuehr J
J Allergy Clin Immunol; 2002 Nov; 110(5):728-35. PubMed ID: 12417881
[TBL] [Abstract][Full Text] [Related]
39. Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy.
Movérare R; Elfman L; Björnsson E; Stålenheim G
Immunol Lett; 2000 Jul; 73(1):51-6. PubMed ID: 10963811
[TBL] [Abstract][Full Text] [Related]
40. Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses.
Puggioni F; Durham SR; Francis JN
Allergy; 2005 May; 60(5):678-84. PubMed ID: 15813815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
